Company Overview of Cadence Pharmaceuticals Inc.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. The company holds the rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever in adults and children. It distributes its products primarily through drug wholesalers to anesthesiologists and surgeons, as well as nurse anesthetists, emergency medicine physicians, intensivists, internists, hospitalists, obstetricians, and other ph...
12481 High Bluff Drive
San Diego, CA 92130
Founded in 2004
Key Executives for Cadence Pharmaceuticals Inc.
Senior Vice President of Regulatory Affairs
Chief Commercial Officer and Senior Vice President
Compensation as of Fiscal Year 2014.
Cadence Pharmaceuticals Inc. Key Developments
Cadence Pharmaceuticals Inc.(NasdaqGM:CADX) dropped from NASDAQ Biotechnology Index
Mar 23 14
Cadence Pharmaceuticals Inc. will be removed from the NASDAQ Biotechnology Index.
Cadence Pharmaceuticals Inc.(NasdaqGM:CADX) dropped from Russell 2000 Index
Mar 20 14
Cadence Pharmaceuticals Inc. will be removed from the Russell 2000 Index.
Cadence Pharmaceuticals Inc.(NasdaqGM:CADX) dropped from Russell 3000 Index
Mar 20 14
Cadence Pharmaceuticals Inc. will be removed from the Russell 3000 Index.
Similar Private Companies By Industry
Recent Private Companies Transactions
February 11, 2014
Most Searched Private Companies
Sponsored Financial Commentaries